Halofuginone lactate

Cat. No.: OB0225LY-0196

Appearance: Solid

Purity: ≥99%

Identity: Confirmed by NMR, HPLC, and LC-MS.

Size:

INQUIRY Datasheet MSDS

Product Overview

Description: Halofuginone lactate is a small molecule compound with anti-inflammatory and anti-fibrotic properties, acting primarily on the TGF-β signaling pathway.

Synonym: 82186-71-8; rac-Halofuginone; 2-Hydroxypropanoic acid; 7-Bromo-6-chloro-3-{3-[(3R)-3-hydroxypiperidin-2-yl]-2-oxopropyl}-3,4-dihydroquinazolin-4-one; 7-Bromo-6-chloro-3-[3-[(3R)-3-hydroxy-2-piperidyl]-2-oxo-propyl]quinazolin-4-one; 7-Bromanyl-6-chloranyl-3-[2-oxidanylidene-3-(3-oxidanylpiperidin-2-yl)propyl]quinazolin-4-one 2-oxidanylpropanoic acid; 7-Bromo-6-chloro-3-[3-(3-hydroxypiperidin-2-yl)-2-oxopropyl]quinazolin-4-one; 2-hydroxypropanoic acid

CAS No.: 82186-71-8

Compound CID: 23623921

Formula: C₁₉H₂₃BrClN₃O₆

Formula Weight: 504.8

Specification

Stability: 3 years in powder form.

Storage: Storage at -20°C.

Applications: Halofuginone lactate can be used to study the mechanisms of fibrosis-related diseases or play an important role in immunomodulation and regenerative medicine.